1887

Abstract

A suicidal DNA vaccine based on a Semliki Forest virus (SFV) replicon was evaluated for the development of a vaccine against swine vesicular disease virus (SVDV). The 1BCD gene of SVDV was cloned and inserted into pSCA1, an SFV DNA-based replicon vector. The resultant plasmid, pSCA/1BCD, was transfected into BHK-21 cells and the antigenicity of the expressed protein was confirmed using an indirect immunofluorescence assay. Immunogenicity was studied in guinea pigs and swine. Animals were injected intramuscularly three times with pSCA/1BCD at regular intervals. Anti-SVDV antibodies were detected by ELISA, the lymphocyte proliferation response was tested by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide method and neutralizing antibodies were measured by microneutralization tests. The data showed that SVDV-specific antibodies, neutralizing antibodies and lymphocyte proliferation were induced in both guinea pigs and swine. Furthermore, after three successive vaccinations with pSCA/1BCD, half of the pigs were protected against challenge with SVDV. These results should encourage further work towards the development of a DNA vaccine against SVDV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82504-0
2007-03-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/3/842.html?itemId=/content/journal/jgv/10.1099/vir.0.82504-0&mimeType=html&fmt=ahah

References

  1. Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, I. & Liljeström, P. ( 1998; ). Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 16, 562–565.[CrossRef]
    [Google Scholar]
  2. Borrego, B., Carra, E., García-Ranea, J. A. & Brocchi, E. ( 2002a; ). Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus. J Gen Virol 83, 35–44.
    [Google Scholar]
  3. Borrego, B., García-Ranea, J. A., Douglas, A. & Brocchi, E. ( 2002b; ). Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies. J Gen Virol 83, 1387–1395.
    [Google Scholar]
  4. Brocchi, E., Zhang, G., Knowels, N. J., Wilsden, G., McCauley, J. W., Marquardt, O., Ohlinger, V. F. & De Simone, F. ( 1997; ). Molecular epidemiology of recent outbreaks of swine vesicular disease: two genetically and antigenically distinct variants in Europe, 1987–94. Epidemiol Infect 118, 51–61.[CrossRef]
    [Google Scholar]
  5. Davis, N. L., Willis, L. V., Smith, J. F. & Johnston, R. E. ( 1989; ). In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology 171, 189–204.[CrossRef]
    [Google Scholar]
  6. Deshpande, M. S., Ambagala, T. C., Hegde, N. R., Hariharan, M. J., Navaratnam, M. & Srikumaran, S. ( 2002; ). Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 20, 3744–3751.[CrossRef]
    [Google Scholar]
  7. DiCiommo, D. P. & Bremner, R. ( 1998; ). Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 273, 18060–18066.[CrossRef]
    [Google Scholar]
  8. Dubensky, T. W., Jr, Driver, D. A., Polo, J. M., Belli, B. A., Latham, E. M., Ibanez, C. E., Chada, S., Brumm, D., Banks, T. A. & other authors ( 1996; ). Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 70, 508–519.
    [Google Scholar]
  9. Gourreau, J. M., Dhennin, L. & Labie, J. ( 1975; ). Preparation of an inactivated virus vaccine against swine vesicular disease. Rec Med Vet Ec Alfort 151, 85–89.
    [Google Scholar]
  10. Guo, H., Liu, Z., Sun, S., Bao, H., Chen, Y., Liu, X. & Xie, Q. ( 2005; ). Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. Vaccine 23, 3236–3242.[CrossRef]
    [Google Scholar]
  11. Gurunathan, S., Klinman, D. M. & Seder, R. A. ( 2000; ). DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18, 927–974.[CrossRef]
    [Google Scholar]
  12. Hariharan, M. J., Driver, D. A., Townsend, K., Brumm, D., Polo, J. M., Belli, B. A., Catton, D. J., Hsu, D., Mittelstaedt, D. & other authors ( 1998; ). DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 72, 950–958.
    [Google Scholar]
  13. Herweijer, H., Latendresse, J. S., Williams, P., Zhang, G., Danko, I., Schlesinger, S. & Wolff, J. A. ( 1995; ). A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther 6, 1161–1167.[CrossRef]
    [Google Scholar]
  14. Hosie, M. J., Flynn, J. N., Rigby, M. A., Cannon, C., Dunsford, T., Mackay, N. A., Argyle, D., Willett, B. J., Miyazawa, T. & other authors ( 1998; ). DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol 72, 7310–7319.
    [Google Scholar]
  15. Jiménez-Clavero, M. A., Escribano-Romero, E., Sanchez-Vizcaino, J. M. & Ley, V. ( 1998; ). Molecular cloning, expression and immunological analysis of the capsid precursor polypeptide (P1) from swine vesicular disease virus. Virus Res 57, 163–170.[CrossRef]
    [Google Scholar]
  16. Jiménez-Clavero, M. A., Douglas, A., Lavery, T., Garcia-Ranea, J. A. & Ley, V. ( 2000; ). Immune recognition of swine vesicular disease virus structural proteins: novel antigenic regions that are not exposed in the capsid. Virology 270, 76–83.[CrossRef]
    [Google Scholar]
  17. Kanno, T., Inoue, T., Wang, Y. F., Sarai, A. & Yamaguchi, S. ( 1995; ). Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants. J Gen Virol 76, 3099–3106.[CrossRef]
    [Google Scholar]
  18. Kim, T. W., Hung, C. F., Juang, J., He, L., Hardwick, J. M. & Wu, T. C. ( 2004; ). Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death. Gene Ther 11, 336–342.[CrossRef]
    [Google Scholar]
  19. Kirman, J. R., Turon, T., Su, H., Li, A., Kraus, C., Polo, J. M., Belisle, J., Morris, S. & Seder, R. A. ( 2003; ). Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun 71, 575–579.[CrossRef]
    [Google Scholar]
  20. Kohno, A., Emi, N., Kasai, M., Tanimoto, M. & Saito, H. ( 1998; ). Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death. Gene Ther 5, 415–418.[CrossRef]
    [Google Scholar]
  21. Leitner, W. W., Ying, H. & Restifo, N. P. ( 1999; ). DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 18, 765–777.[CrossRef]
    [Google Scholar]
  22. Leitner, W. W., Ying, H., Driver, D. A., Dubensky, T. W. & Restifo, N. P. ( 2000; ). Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res 60, 51–55.
    [Google Scholar]
  23. Leitner, W. W., Hwang, L. N., DeVeer, M. J., Zhou, A., Silverman, R. H., Williams, B. R., Dubensky, T. W., Ying, H. & Restfo, N. P. ( 2003; ). Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9, 33–39.
    [Google Scholar]
  24. Lewis, P. J. & Babiuk, L. A. ( 1999; ). DNA vaccines: a review. In Advances in Virus Research, pp. 129–188. Edited by K. Maramorosch, F. A. Murphy & A. J. Shatkin. San Diego, CA: Academic Press.
  25. Liljestrom, P. & Garoff, H. ( 1991; ). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) 9, 1356–1361.[CrossRef]
    [Google Scholar]
  26. Lundstrom, K. ( 2000; ). Alphavirus vectors: applications for DNA vaccines production and gene expression. Intervirology 43, 247–257.[CrossRef]
    [Google Scholar]
  27. Mitev, G., Tekerlekov, P., Dilovdky, M., Ognianov, D. & Nikolova, E. ( 1978; ). Experiments on the preparation and testing of associated vaccine against foot and mouth disease and vesicular disease in swine. Arch Exp Veterinarmed 32, 29–33.
    [Google Scholar]
  28. Morris-Downes, M. M., Phenix, K. V., Smyth, J., Sheahan, B. J., Lileqvist, S., Mooney, D. A., Liljestrom, P., Todd, D. & Atkins, G. J. ( 2001; ). Semliki forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems. Vaccine 19, 1978–1988.[CrossRef]
    [Google Scholar]
  29. Nardelli, L., Lodetti, G., Gualandi, G., Burrows, R., Goodridge, D., Brown, F. & Cartwright, B. ( 1968; ). A foot-and-mouth disease syndrome in pigs caused by an enterovirus. Nature 219, 1275–1276.[CrossRef]
    [Google Scholar]
  30. Nijhar, S. K., Mackay, D. K., Brocchi, E., Ferris, N. P., Kitching, R. P. & Knowles, N. J. ( 1999; ). Identification of neutralizing epitopes on a European strain of swine vesicular disease virus. J Gen Virol 80, 277–282.
    [Google Scholar]
  31. Rebel, J. M., Leendertse, C. H., Dekker, A., van Poelwijk, F. & Moormann, R. J. ( 2000; ). Construction of a full-length infectious cDNA clone of swine vesicular disease virus strain NET/1/92 and analysis of new antigenic variants derived from it. J Gen Virol 81, 2763–2769.
    [Google Scholar]
  32. Vidalin, O., Fournillier, A., Renard, N., Chen, M., Depla, E., Boucreux, D., Brinster, C., Baumert, T., Nakano, I. & other authors ( 2000; ). Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens. Virology 276, 259–270.[CrossRef]
    [Google Scholar]
  33. Xiao, S., Chen, H., Fang, L., Liu, C., Zhang, H., Jiang, Y. & Hong, W. ( 2004; ). Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22, 345–351.[CrossRef]
    [Google Scholar]
  34. Ye, G., Liu, X., Zhang, Y., Ma, Y., Zhang, M., Han, X., Zhang, Y. & Xie, Q. ( 2005; ). Determination and analysis of complete nucleotide sequence of swine vesicular disease virus. Chin J Virol 21, 60–71.
    [Google Scholar]
  35. Zarozinski, C. C., Fynan, E. F., Selin, L. K., Robinson, H. L. & Welsh, R. M. ( 1995; ). Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol 154, 4010–4017.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82504-0
Loading
/content/journal/jgv/10.1099/vir.0.82504-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error